What the market will bear

I started college at the dawning of the age of cloning. Recombinant DNA technology represented the transition from descriptive molecular biology to genetic engineering. By the time I started teaching medical students, the genes mutated in terrible diseases like cystic fibrosis, Tay-Sachs, hemophilia and Fragile X were being cloned. There was always an obligatory paragraph […]